A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Clinical trial NCT04857372 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04857372
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2027-01-07
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.